{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:07:23Z","timestamp":1790525243390,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T00:00:00Z","timestamp":1547251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Research Foundation (NRF) of Korea and Korea Health Technology Research and Development Project, Ministry for Health and Welfare Affairs","award":["NRF2017R1C1B1011397, HI16C1559, HI18C0183"],"award-info":[{"award-number":["NRF2017R1C1B1011397, HI16C1559, HI18C0183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12035-019-1468-7","type":"journal-article","created":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T22:56:14Z","timestamp":1547333774000},"page":"5539-5554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Nanocarrier-mediated Delivery of CORM-2 Enhances Anti-allodynic and Anti-hyperalgesic Effects of CORM-2"],"prefix":"10.1007","volume":"56","author":[{"given":"Hari Prasad","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jae","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Won","family":"Kyung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seil","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-0245","authenticated-orcid":false,"given":"In-Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,12]]},"reference":[{"key":"1468_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fphar.2017.00048","volume":"8","author":"AM Jurga","year":"2017","unstructured":"Jurga AM, Piotrowska A, Makuch W, Przewlocka B, Mika J (2017) Blockade of P2X4 receptors inhibits neuropathic pain-related behavior by preventing MMP-9 activation and, consequently, pronociceptive interleukin release in a rat model. Front Pharmacol 8:48","journal-title":"Front Pharmacol"},{"key":"1468_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bcp.2017.12.007","volume":"148","author":"G Riego","year":"2018","unstructured":"Riego G, Redondo A, Le\u00e1nez S, Pol O (2018) Mechanism implicated in the anti-allodynic and anti-hyperalgesic effects induced by the activation of heme oxygenase 1\/carbon monoxide signaling pathway in the central nervous system of mice with neuropathic pain. Biochem Pharmacol 148:52\u201363","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanp\u00e4\u00e4 M, Kalso E, Loeser JD, Rice AS, Treede R-D (2011) A new definition of neuropathic pain. Pain 152(10):2204\u20132205","journal-title":"Pain"},{"issue":"8","key":"1468_CR4","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, Cruccu G, Freeman R et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157(8):1599\u20131606","journal-title":"Pain"},{"issue":"3","key":"1468_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/bies.20005","volume":"26","author":"SW Ryter","year":"2004","unstructured":"Ryter SW, Otterbein LE (2004) Carbon monoxide in biology and medicine. Bioessays 26(3):270\u2013280","journal-title":"Bioessays"},{"issue":"4","key":"1468_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.57.4.3","volume":"57","author":"L Wu","year":"2005","unstructured":"Wu L, Wang R (2005) Carbon monoxide: endogenous production, physiological functions, and pharmacological application. Pharmacol Rev 57(4):585\u2013630","journal-title":"Pharmacol Rev"},{"issue":"9","key":"1468_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrd3228","volume":"9","author":"R Motterlini","year":"2010","unstructured":"Motterlini R, Otterbein LE (2010) The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9(9):728\u2013743","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1468_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/74680","volume":"6","author":"LE Otterbein","year":"2000","unstructured":"Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, Davis RJ, Flavell RA et al (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6(4):422\u2013428","journal-title":"Nat Med"},{"issue":"2","key":"1468_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm817","volume":"9","author":"LE Otterbein","year":"2003","unstructured":"Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N et al (2003) Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9(2):183\u2013190","journal-title":"Nat Med"},{"issue":"4","key":"1468_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00134-008-1011-1","volume":"34","author":"R Foresti","year":"2008","unstructured":"Foresti R, Bani-Hani MG, Motterlini R (2008) Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 34(4):649\u2013658","journal-title":"Intensive Care Med"},{"issue":"9","key":"1468_CR11","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1039\/c2cs15317c","volume":"41","author":"CC Romao","year":"2012","unstructured":"Romao CC, Bl\u00e4ttler WA, Seixas JD, Bernardes GJ (2012) Developing drug molecules for therapy with carbon monoxide. Chem Soc Rev 41(9):3571\u20133583","journal-title":"Chem Soc Rev"},{"issue":"16","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1021\/om300360c","volume":"31","author":"AR Marques","year":"2012","unstructured":"Marques AR, Kromer L, Gallo DJ, Penacho N, Rodrigues SS, Seixas JD, Bernardes GJ, Reis PM et al (2012) Generation of carbon monoxide releasing molecules (CO-RMs) as drug candidates for the treatment of acute liver injury: targeting of CO-RMs to the liver. Organometallics 31(16):5810\u20135822","journal-title":"Organometallics"},{"key":"1468_CR13","doi-asserted-by":"crossref","unstructured":"Motterlini R (2007) Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Portland Press Limited","DOI":"10.1042\/BST0351142"},{"issue":"1","key":"1468_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2045-9912-2-28","volume":"2","author":"R Motterlini","year":"2012","unstructured":"Motterlini R, Haas B, Foresti R (2012) Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs). Med Gas Res 2(1):28","journal-title":"Med Gas Res"},{"issue":"11","key":"1468_CR15","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1111\/j.2042-7158.2010.01024.x","volume":"62","author":"H Bunjes","year":"2010","unstructured":"Bunjes H (2010) Lipid nanoparticles for the delivery of poorly water-soluble drugs. J Pharm Pharmacol 62(11):1637\u20131645","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"1468_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47(2):165\u2013196","journal-title":"Adv Drug Deliv Rev"},{"issue":"25","key":"1468_CR17","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1021\/la301605a","volume":"28","author":"Y Chenglin","year":"2012","unstructured":"Chenglin Y, Yiqun Y, Ye Z, Na L, Xiaoya L, Jing L, Ming J (2012) Self-assembly and emulsification of poly {[styrene-alt-maleic acid]-co-[styrene-alt-(N-3, 4-dihydroxyphenylethyl-maleamic acid)]}. Langmuir 28(25):9211\u20139222","journal-title":"Langmuir"},{"key":"1468_CR18","first-page":"10","volume":"1","author":"P Severino","year":"2012","unstructured":"Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MHA, Silva AM, Souto EB (2012) Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliver 1:10","journal-title":"J Drug Deliver"},{"issue":"1","key":"1468_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, Ma\u00c8der K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art. Eur J Pharm Biopharm 50(1):161\u2013177","journal-title":"Eur J Pharm Biopharm"},{"key":"1468_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2014.05.029","volume":"193","author":"JV Natarajan","year":"2014","unstructured":"Natarajan JV, Nugraha C, Ng XW, Venkatraman S (2014) Sustained-release from nanocarriers: a review. J Control Release 193:122\u2013138","journal-title":"J Control Release"},{"issue":"Suppl 2","key":"1468_CR21","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/089686089301302S09","volume":"13","author":"B Rippe","year":"1993","unstructured":"Rippe B (1993) A three-pore model of peritoneal transport. Perit Dial Int 13(Suppl 2):S35\u2013S38","journal-title":"Perit Dial Int"},{"key":"1468_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejpb.2016.09.008","volume":"108","author":"OS Qureshi","year":"2016","unstructured":"Qureshi OS, Zeb A, Akram M, Kim M-S, Kang J-H, Kim H-S, Majid A, Han I et al (2016) Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery. Eur J Pharm Biopharm 108:187\u2013195","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1468_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/02652048.2017.1337247","volume":"34","author":"OS Qureshi","year":"2017","unstructured":"Qureshi OS, Kim H-S, Zeb A, Choi J-S, Kim H-S, Kwon J-E, Kim M-S, Kang J-H et al (2017) Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration. J Microencapsul 34(3):250\u2013261","journal-title":"J Microencapsul"},{"issue":"21","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1039\/c0dt01809k","volume":"40","author":"AJ Atkin","year":"2011","unstructured":"Atkin AJ, Lynam JM, Moulton BE, Sawle P, Motterlini R, Boyle NM, Pryce MT, Fairlamb IJ (2011) Modification of the deoxy-myoglobin\/carbonmonoxy-myoglobin UV-Vis assay for reliable determination of CO-release rates from organometallic carbonyl complexes. Dalton Trans 40(21):5755\u20135761","journal-title":"Dalton Trans"},{"issue":"2","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1161\/hh0202.104530","volume":"90","author":"R Motterlini","year":"2002","unstructured":"Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ (2002) Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90(2):e17\u2013e24","journal-title":"Circ Res"},{"issue":"1","key":"1468_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","volume":"33","author":"GJ Bennett","year":"1988","unstructured":"Bennett GJ, Xie Y-K (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33(1):87\u2013107","journal-title":"Pain"},{"issue":"3","key":"1468_CR27","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1590\/0001-3765201420130404","volume":"86","author":"VR Thiagarajan","year":"2014","unstructured":"Thiagarajan VR, Shanmugam P, Krishnan UM, Muthuraman A (2014) Ameliorative potential of Vernonia cinerea on chronic constriction injury of sciatic nerve induced neuropathic pain in rats. An Acad Bras Cienc 86(3):1435\u20131450","journal-title":"An Acad Bras Cienc"},{"issue":"5","key":"1468_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/ALN.0b013e318286d085","volume":"118","author":"A Hervera","year":"2013","unstructured":"Hervera A, Le\u00e1nez S, Motterlini R, Pol O (2013) Treatment with carbon monoxide-releasing molecules and an HO-1 inducer enhances the effects and expression of \u03bc-opioid receptors during neuropathic pain. Anesthesiol: J Am Soc Anesthesiol 118(5):1180\u20131197","journal-title":"Anesthesiol: J Am Soc Anesthesiol"},{"issue":"1","key":"1468_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12906-017-1807-z","volume":"17","author":"M Shahid","year":"2017","unstructured":"Shahid M, Subhan F, Ahmad N, Ullah I (2017) A bacosides containing Bacopa monnieri extract alleviates allodynia and hyperalgesia in the chronic constriction injury model of neuropathic pain in rats. BMC Complement Altern Med 17(1):293","journal-title":"BMC Complement Altern Med"},{"issue":"1\u20132","key":"1468_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0304-3959(02)00039-8","volume":"98","author":"HK Erichsen","year":"2002","unstructured":"Erichsen HK, Blackburn-Munro G (2002) Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 98(1\u20132):151\u2013161","journal-title":"Pain"},{"issue":"5","key":"1468_CR31","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1213\/ANE.0000000000000174","volume":"118","author":"C Zhou","year":"2014","unstructured":"Zhou C, Shi X, Huang H, Zhu Y, Wu Y (2014) Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury. Anesth Analg 118(5):1090\u20131096","journal-title":"Anesth Analg"},{"issue":"1","key":"1468_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3892\/or.2016.5241","volume":"37","author":"C-H Guo","year":"2017","unstructured":"Guo C-H, Bai L, Wu H-H, Yang J, Cai G-H, Zeng S-X, Wang X, Wu S-X et al (2017) Midazolam and ropivacaine act synergistically to inhibit bone cancer pain with different mechanisms in rats. Oncol Rep 37(1):249\u2013258","journal-title":"Oncol Rep"},{"issue":"1","key":"1468_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1742-2094-8-33","volume":"8","author":"JV Berger","year":"2011","unstructured":"Berger JV, Deumens R, Goursaud S, Sch\u00e4fer S, Lavand\u2019homme P, Joosten EA, Hermans E (2011) Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1. J Neuroinflammation 8(1):33","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1468_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0304-3940(98)00982-3","volume":"260","author":"D Levy","year":"1999","unstructured":"Levy D, H\u00f6ke A, Zochodne DW (1999) Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett 260(3):207\u2013209","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"1468_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pain.2009.02.006","volume":"143","author":"D-S Kim","year":"2009","unstructured":"Kim D-S, Figueroa KW, Li K-W, Boroujerdi A, Yolo T, Luo ZD (2009) Profiling of dynamically changed gene expression in dorsal root ganglia post peripheral nerve injury and a critical role of injury-induced glial fibrillary acetic protein in maintenance of pain behaviors. Pain 143(1\u20132):114\u2013122","journal-title":"Pain"},{"key":"1468_CR36","doi-asserted-by":"crossref","unstructured":"Olmos G, Llad\u00f3 J (2014) Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediat Inflamm","DOI":"10.1155\/2014\/861231"},{"issue":"1","key":"1468_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00210-012-0816-1","volume":"386","author":"KRV Bijjem","year":"2013","unstructured":"Bijjem KRV, Padi SS, lal Sharma P (2013) Pharmacological activation of heme oxygenase (HO)-1\/carbon monoxide pathway prevents the development of peripheral neuropathic pain in Wistar rats. Naunyn Schmiedeberg\u2019s Arch Pharmacol 386(1):79\u201390","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"11","key":"1468_CR38","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/0028-3908(94)90051-5","volume":"33","author":"S Meller","year":"1994","unstructured":"Meller S, Dykstra C, Grzybycki D, Murphy S, Gebhart G (1994) The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33(11):1471\u20131478","journal-title":"Neuropharmacology"},{"issue":"8","key":"1468_CR39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0166-2236(00)01854-3","volume":"24","author":"LR Watkins","year":"2001","unstructured":"Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24(8):450\u2013455","journal-title":"Trends Neurosci"},{"issue":"2","key":"1468_CR40","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1460-9568.2004.03514.x","volume":"20","author":"V Raghavendra","year":"2004","unstructured":"Raghavendra V, Tanga FY, DeLeo JA (2004) Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20(2):467\u2013473","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1468_CR41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.neuropharm.2008.12.003","volume":"56","author":"M Tanabe","year":"2009","unstructured":"Tanabe M, Nagatani Y, Saitoh K, Takasu K, Ono H (2009) Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 56(3):702\u2013708","journal-title":"Neuropharmacology"},{"issue":"9","key":"1468_CR42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.biopha.2008.01.008","volume":"62","author":"KM Kim","year":"2008","unstructured":"Kim KM, Pae H-O, Zhung M, Ha H-Y, Ha YA, Chai K-Y, Cheong Y-K, Kim J-M et al (2008) Involvement of anti-inflammatory heme oxygenase-1 in the inhibitory effect of curcumin on the expression of pro-inflammatory inducible nitric oxide synthase in RAW264. 7 macrophages. Biomed Pharmacother 62(9):630\u2013636","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1468_CR43","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1089\/ars.2013.5658","volume":"20","author":"R Motterlini","year":"2014","unstructured":"Motterlini R, Foresti R (2014) Heme oxygenase-1 as a target for drug discovery. Antioxid Redox Signal 20(11):1810\u20131826","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"1468_CR44","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0306-4522(03)00483-4","volume":"121","author":"D Liang","year":"2003","unstructured":"Liang D, Li X, Lighthall G, Clark J (2003) Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine. Neuroscience 121(4):999\u20131005","journal-title":"Neuroscience"}],"updated-by":[{"DOI":"10.1007\/s12035-019-1520-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1468-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T11:24:31Z","timestamp":1606044271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1468-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,12]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1468-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12035-019-1520-7","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,12]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article, the name of author was incorrectely presented. That is Kyungjae Won (K. Won) should be presented as <Emphasis Type=\"Bold\">Jae Won Kyung<\/Emphasis> (J.W. Kyung).","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}